NGNE vs. META

Last updated Jul 11, 2026

NGNE (Neurogene Inc) and META (Meta Platforms, Inc.) are both stocks. NGNE operates in Biotechnology (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 10 years, NGNE returned -12.30%/yr vs 19.06%/yr for META. At a 0.18 correlation, their price movements are largely independent.

Performance

NGNE vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neurogene Inc (NGNE) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NGNE achieves a 92.38% return, which is significantly higher than META's 1.56% return. Over the past 10 years, NGNE has underperformed META with an annualized return of -12.30%, while META has yielded a comparatively higher 19.06% annualized return.

NGNE

• 1D: -7.49%
• 1M: 36.19%
• 6M: 121.15%
• YTD: 92.38%
• 1Y: 84.93%
• 3Y*: 32.70%
• 5Y*: -26.46%
• 10Y*: -12.30%

META

• 1D: 5.97%
• 1M: 18.14%
• 6M: 2.66%
• YTD: 1.56%
• 1Y: -6.43%
• 3Y*: 31.29%
• 5Y*: 14.01%
• 10Y*: 19.06%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NGNE vs. META - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NGNE Neurogene Inc	92.38%	-9.89%	17.96%	90.37%	-89.44%	-65.82%	14.45%	470.37%	-81.63%	-28.77%
META Meta Platforms, Inc.	1.56%	13.09%	66.05%	194.13%	-64.22%	23.13%	33.09%	56.57%	-25.71%	53.38%

Correlation

The correlation between NGNE and META is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.21
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Mar 7, 2014	0.18

Fundamentals

Market Cap NGNE : $626.25M META : $1.70T
EPS NGNE : -$5.02 META : $27.47
PB Ratio NGNE : 3.72 META : 7.04
Total Revenue (TTM) NGNE : $0.00 META : $214.96B
Gross Profit (TTM) NGNE : -$787.00K META : $176.14B
EBITDA (TTM) NGNE : -$101.52M META : $106.31B

Return for Risk

NGNE vs. META — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NGNE

NGNE Risk / Return Rank: 74
NGNE Sharpe Ratio Rank: 75
NGNE Sortino Ratio Rank: 77
NGNE Omega Ratio Rank: 73
NGNE Calmar Ratio Rank: 74
NGNE Martin Ratio Rank: 69

META

META Risk / Return Rank: 35
META Sharpe Ratio Rank: 37
META Sortino Ratio Rank: 33
META Omega Ratio Rank: 33
META Calmar Ratio Rank: 38
META Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NGNE vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neurogene Inc (NGNE) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NGNE	META	Difference
Sharpe ratio: Return per unit of total volatility	0.98	-0.20	+1.18
Sortino ratio: Return per unit of downside risk	1.82	-0.03	+1.84
Omega ratio: Gain probability vs. loss probability	1.21	1.00	+0.21
Calmar ratio: Return relative to maximum drawdown	1.54	-0.23	+1.78
Martin ratio: Return relative to average drawdown	2.75	-0.44	+3.19

NGNE vs. META - Sharpe Ratio Comparison

The current NGNE Sharpe Ratio is 0.98, which is higher than the META Sharpe Ratio of -0.20. The chart below compares the historical Sharpe Ratios of NGNE and META, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NGNE vs. META - Drawdown Comparison

The maximum NGNE drawdown since its inception was -98.34%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for NGNE and META.

Drawdown Indicators

	NGNE	META	Difference
Max Drawdown Largest peak-to-trough decline	-98.34%	-76.74%	-21.60%
Max Drawdown (1Y) Largest decline over 1 year	-52.37%	-33.30%	-19.07%
Max Drawdown (3Y) Largest decline over 3 years	-89.74%	-34.15%	-55.59%
Max Drawdown (5Y) Largest decline over 5 years	-95.85%	-76.74%	-19.11%
Max Drawdown (10Y) Largest decline over 10 years	-98.14%	-76.74%	-21.40%
Current Drawdown Current decline from peak	-91.05%	-15.01%	-76.04%
Average Drawdown Average peak-to-trough decline	-67.96%	-15.88%	-52.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	29.39%	17.46%	+11.93%

Volatility

NGNE vs. META - Volatility Comparison

Neurogene Inc (NGNE) has a higher volatility of 24.49% compared to Meta Platforms, Inc. (META) at 16.03%. This indicates that NGNE's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NGNE	META	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.49%	16.03%	+8.46%
Volatility (6M) Calculated over the trailing 6-month period	56.00%	30.87%	+25.13%
Volatility (1Y) Calculated over the trailing 1-year period	82.94%	38.42%	+44.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	94.00%	44.53%	+49.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.83%	38.96%	+48.87%

Dividends

NGNE vs. META - Dividend Comparison

NGNE has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.31%.

Position	TTM	2025	2024
META Meta Platforms, Inc.	0.31%	0.32%	0.34%
NGNE Neurogene Inc	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both NGNE and META in my portfolio?

NGNE and META have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NGNE or META?

NGNE has higher volatility (24.49%) compared to META (16.03%). In terms of maximum drawdown, NGNE dropped -98.34% vs META's -76.74%.

Which has better risk-adjusted returns?

NGNE currently has the higher Sharpe Ratio (0.98 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.